WINT: Windtree Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3.64
Enterprise Value ($M) 14.55
Book Value ($M) 3.39
Book Value / Share 0.37
Price / Book 1.07
NCAV ($M) -23.64
NCAV / Share -2.57
Price / NCAV -0.15

Profitability (mra)
Return on Invested Capital (ROIC) -1.00
Return on Assets (ROA) -0.58
Return on Equity (ROE) -2.89

Liquidity (mrq)
Quick Ratio 1.35
Current Ratio 1.35

Balance Sheet (mrq) ($M)
Current Assets 5.38
Assets 32.41
Liabilities 29.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.84
Net Income -20.29
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -13.44
Cash from Investing -0.01
Cash from Financing 11.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Lincoln Park Capital Fund, LLC 6.18 -26.11
02-13 13G/A Lind Global Fund II LP 5.30 -38.94
02-01 13G Flynn James E 7.59
11-13 13G Duvvuri Krishna 6.35
05-17 13D/A Huang James 1.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 142,877 456,185 31.32
2024-04-18 571,107 1,675,484 34.09
2024-04-17 12,417 104,058 11.93
2024-04-16 61,289 4,144 1,478.98
2024-04-15 32,764 12,680 258.39

(click for more detail)

Similar Companies
VTVT – vTv Therapeutics Inc. VXRT – Vaxart, Inc.
VYNE – VYNE Therapeutics Inc. XBIO – Xenetic Biosciences, Inc.
XCUR – Exicure, Inc.


Financial data and stock pages provided by
Fintel.io